What they principally cannot do, regardless of their effectiveness in depleting the extracellular Aβ pool or suppressing the production of Aβ in the AβPP proteolytic pathway, is be effective in settings where the AD Engine, i.e., the self-sustainable AβPP-independent C99/iAβ generation pathway is active. The gene discussed is APP; the disease is Alzheimer disease.